Primecap Management Portfolio holdings
AUM
$126B
This Quarter Return
+11.97%
1 Year Return
+17.42%
3 Year Return
+102.42%
5 Year Return
+196.08%
10 Year Return
+554.06%
AUM
$109B
AUM Growth
+$5.89B
(+5.7%)
Cap. Flow
-$3.73B
Cap. Flow
% of AUM
-3.42%
Top 10 Holdings %
Top 10 Hldgs %
32.97%
Holding
343
New
8
Increased
53
Reduced
229
Closed
9
Top Buys
| 1 |
SPLK
Splunk Inc
SPLK
|
$175M |
| 2 |
Fidelity National Information Services
FIS
|
$134M |
| 3 |
Intel
INTC
|
$118M |
| 4 |
GSK
GSK
|
$117M |
| 5 |
Mobileye
MBLY
|
$72.3M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$777M |
| 2 |
ABMD
Abiomed Inc
ABMD
|
$370M |
| 3 |
Microsoft
MSFT
|
$294M |
| 4 |
Charles Schwab
SCHW
|
$212M |
| 5 |
Hewlett Packard
HPE
|
$146M |
Sector Composition
| 1 | Healthcare | 33.81% |
| 2 | Technology | 27.18% |
| 3 | Industrials | 11.89% |
| 4 | Financials | 8.82% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
UnitedHealth
UNH
$279B
| $8.5M | 0.01% |
16,034
| – | – |
|
|
GTM
252
ZoomInfo Technologies
GTM
$3.31B
| $8.3M | 0.01% |
275,569
-2,950
| -1% | -$88.8K |
|
253
Darden Restaurants
DRI
$24.3B
| $8.26M | 0.01% |
59,700
| – | – |
|
254
CyberArk
CYBR
$23B
| $8.2M | 0.01% |
63,250
-16,100
| -20% | -$2.09M |
|
255
Repligen
RGEN
$6.54B
| $8.02M | 0.01% |
47,379
| – | – |
|
256
New Fortress Energy
NFE
$631M
| $7.95M | 0.01% |
187,300
+1,700
| +0.9% | +$72.1K |
|
257
Schlumberger
SLB
$52.2B
| $7.86M | 0.01% |
147,100
+8,000
| +6% | +$428K |
|
258
PROS Holdings
PRO
$734M
| $7.71M | 0.01% |
317,630
-29,660
| -9% | -$720K |
|
259
Enovis
ENOV
$1.75B
| $7.66M | 0.01% |
143,066
| – | – |
|
260
Ambarella
AMBA
$3.36B
| $7.52M | 0.01% |
91,400
-22,300
| -20% | -$1.83M |
|
261
DoorDash
DASH
$106B
| $7.13M | 0.01% |
145,990
-300
| -0.2% | -$14.6K |
|
262
Constellation Brands
STZ
$25.8B
| $6.98M | 0.01% |
30,100
| – | – |
|
263
BridgeBio Pharma
BBIO
$9.91B
| $6.96M | 0.01% |
913,292
-124,438
| -12% | -$948K |
|
264
ESAB
ESAB
$6.92B
| $6.71M | 0.01% |
143,065
| – | – |
|
265
Omnicell
OMCL
$1.51B
| $6.61M | 0.01% |
131,107
+21,850
| +20% | +$1.1M |
|
266
Rapid7
RPD
$1.32B
| $6.58M | 0.01% |
193,500
+12,900
| +7% | +$438K |
|
267
Rivian
RIVN
$17.5B
| $6.4M | 0.01% |
347,500
-4,520
| -1% | -$83.3K |
|
268
GitLab
GTLB
$7.75B
| $5.99M | 0.01% |
131,790
-1,030
| -0.8% | -$46.8K |
|
269
Dollar General
DG
$24.1B
| $5.81M | 0.01% |
23,600
+6,500
| +38% | +$1.6M |
|
|
AMK
270
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $5.79M | 0.01% |
251,700
| – | – |
|
271
EPR Properties
EPR
$4.06B
| $5.59M | 0.01% |
148,280
-23,720
| -14% | -$895K |
|
272
Guardant Health
GH
$8.11B
| $5.5M | 0.01% |
202,044
-27,000
| -12% | -$734K |
|
273
Standard BioTools
LAB
$493M
| $5.4M | ﹤0.01% |
4,616,673
-310,070
| -6% | -$363K |
|
274
Ciena
CIEN
$13.4B
| $5.17M | ﹤0.01% |
101,485
+1,000
| +1% | +$51K |
|
275
Health Catalyst
HCAT
$228M
| $5.01M | ﹤0.01% |
471,334
-910
| -0.2% | -$9.67K |
|